Physician profile
Mircea Tudor Iacob
NPI 1588617856
$50,080.99
in general payments reported to CMS, 2019-2025
8 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 77% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,195 · 2021: $7,156 · 2022: $6,847 · 2023: $5,023 · 2024: $11K · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $3,315 · Food and Beverage: $1,003 · Education: $17.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,842.50 |
| Travel and Lodging | $3,314.99 |
| Food and Beverage | $1,002.88 |
| Education | $17.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $40,026.29 | 2019-2024 | Ultomiris |
| Allergan, INC. | $6,508.28 | 2020-2021 | |
| Livanova USA, INC. | $1,882.19 | 2024-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $1,496.16 | 2021-2025 | |
| Penumbra, INC. | $137.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Emd Serono, INC. | $13.17 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mircea Iacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.